Patent details

Basic Information

Publication number:

EP3866788

PCT Application Number:

US2019056948

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP198014466

PCT Publication Number:

WO2020081941

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF MACULAR INJURY ASSOCIATED WITH MULTIPLE SCLEROSIS WITH IBUDILAST

French Title of Invention:

TRAITEMENT AVEC IBUDILAST DES LESIONS MACULAIRES ASSOCIEES AVEC LA SCLEROSE EN PLAQUE

German Title of Invention:

BEHANDLUNG VON MIT MULTIPLER SKLEROSE VERBUNDENER MAKULARER VERLETZUNG MIT IBUDILAST

SPC Number:

Dates

Filing date:

18/10/2019

Grant date:

13/12/2023

EP Publication Date:

25/08/2021

PCT Publication Date:

23/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2023

EP B1 Publication Date:

13/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/10/2024

Expiration date:

18/10/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/12/2023

 

 

Name:

MediciNova, Inc.

Address:

4275 Executive Square Suite 300, La Jolla, CA 92037, United States (US)

Inventor

Name:

MATSUDA, Kazuko

Address:

United States (US)

Priority

Priority Number:

201862748148 P

Priority Date:

19/10/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/416; A61P 25/28;

Publication

European Patent Bulletin

Issue number:

202350

Publication date:

13/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages